• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI INTECC CO., LTD. ASAHI GLADIUS MONGO 14 ES; PTCA GUIDE WIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI INTECC CO., LTD. ASAHI GLADIUS MONGO 14 ES; PTCA GUIDE WIRE Back to Search Results
Model Number N/A
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Codes Vessel Or Plaque, Device Embedded In (1204); Device Embedded In Tissue or Plaque (3165)
Date of Event 05/07/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Single reporter exemption #e2015028.The importer report number used for this report was generated from the importer registration number, current year, and sequential number that match the manufacturer report number.Device evaluation could not be performed because the device was discarded by the facility.Lot history review revealed no anomaly relating to the reported event.No other similar product experience report was received from this lot.Based on the obtained information and referring to known incidents, it was presumed that wire manipulation was continued while the wire tip was probably being trapped in the severely calcified cto or caught by the existing stent.When repeated bending stress and torsion generated with wire manipulation exceeded the product's design limit, the guide wire became fractured and eventually separated upon wire removal.It was concluded that this event was not attributed to product quality.Instructions for use states that: [warnings] observe movement of this guide wire in the vessels.Before this guide wire is moved or torqued, the tip movement should be examined and monitored under fluoroscopy.Do not move or torque the guide wire without observing corresponding movement of the tip; otherwise, the guide wire may be damaged and/or trauma may occur.In addition, ensure that the distal tip of this guide wire and its location in the vessel are visible during manipulations of the guide wire; [warnings] never push, auger, withdraw, or torque a guidewire that meets the resistance.Torquing or pushing a guidewire against resistance may cause guidewire damage and/or guidewire tip separation or direct damage to a vessel.Resistance may be felt and/or observed under fluoroscopy by noting any bucking of the guidewire tip.If guidewire tip prolapse is observed, do not allow the tip to remain in a prolapsed position; otherwise damage to the guidewire may occur.Determine the cause of resistance under fluoroscopy and take any necessary remedial action; [warnings] if any resistance is felt due to spasm or the guidewire being bent or trapped while operating the guidewire in the blood vessel or removing it, do not move or torque the guidewire.Stop the procedure.Determine the cause of resistance under fluoroscopy and take appropriate remedial action.If the guidewire is moved excessively, it may break or become damaged, which may cause blood vessel injury or result in fragments being left inside the vessel; and, [malfunction and adverse effects] separation of the guide wire.
 
Event or Problem Description
It was reported that the tip of an asahi guide wire separated during a pci to treat a extremely tortuous, severely calcified cto in the proximal rca.According to the physician, the existing stent had been placed years earlier and was probably fractured.Attempts were made with several wires with a 2.0 balloon for support; however, all met with no success.While using the asahi guide wire, it was prolapsed but was subluminal.With the tortuosity, the heavy calcification and the existing stent, the radiopaque portion of the wire broke off and was left in the subintimal space.The piece of wire that was left in the subintimal space was not moving and according to the physician, posed no threat to the patient.A new non-asahi wire was used subsequently with no success in crossing and the case finished.
 
Additional Manufacturer Narrative
Asahi intecc has determined that the date recorded in block b4 "date of this report" was erroneously reported as the date the report was submitted rather than the date the initial reporter provided the information about the event to the company.Corrective action has been taken to clarify which date should be provided in the report.This supplemental report is intended only to correct the date provided in block b4 to reflect the date the initial reporter provided the information about the event to the company.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASAHI GLADIUS MONGO 14 ES
Common Device Name
PTCA GUIDE WIRE
Manufacturer (Section D)
ASAHI INTECC CO., LTD.
3-100 akatsuki-cho
seto, 489-0 071
JA  489-0071
MDR Report Key8606569
Report Number3003775027-2019-00086
Device Sequence Number19418105
Product Code DQX
UDI-Device Identifier04547327123723
UDI-Public(01)04547327123723(17)211031(10)181120A341
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K180784
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/09/2019
Report Date (Section F) 05/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2021
Device Model NumberN/A
Device Catalogue NumberAP14R024S
Device Lot Number181120A341
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/08/2019
Event Location Hospital
Date Report to Manufacturer05/09/2019
Initial Date Received by Manufacturer 05/09/2019
Supplement Date Received by Manufacturer05/09/2019
Initial Report FDA Received Date05/14/2019
Supplement Report FDA Received Date01/23/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Disability;
-
-